News
Intas Pharmaceuticals has completed its acquisition of the UDENYCA (pegfilgrastim-cbqv) business from Coherus BioSciences Inc ...
8h
Pharmaceutical Technology on MSNCoherus divests Udenyca franchise to Intas for up to $558.4mCoherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals under an ...
Coherus BioSciences (CHRS) announced the completion of the previously announced divestiture of its UDENYCA franchise to Intas Pharmaceuticals ...
Learn about Fiale Pharmaceuticals in Indore, Madhya Pradesh.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...
The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely.
Tariffs on pharmaceuticals would go against a duty-free agreement that the U.S. signed on to under the World Trade Organization, which barely held up during Trump’s first term. Under the 1994 ...
President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs he has already imposed on most goods entering the United States ...
Indore: The meetings, incentives, conferences and exhibitions (MICE) tourism sector in Madhya Pradesh is witnessing a significant resurgence, leading to increased hotel occupancy at various ...
April 8 (Reuters) - President Donald Trump on Tuesday said the U.S. will soon announce a "major" tariff on pharmaceutical imports. Speaking to an event at the National Republican Congressional ...
Imagicaaworld Entertainment Limited launched its new Aqua Imagicaa water park in Indore, Madhya Pradesh today, marking the company’s expansion into central India. The 18-acre facility ...
My wife and I would both be dead, but for what many derisively call “Big Pharma.” My wife has a rare, genetic form of stage four lung cancer for which there is no cure. Her lungs are filled ...
Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results